Electrical Muscle Stimulation for Stroke Balance and Fall Risk
(NMES Trial)
Trial Summary
What is the purpose of this trial?
The aim of this study is to describe the effect of neuromuscular electrical stimulation (NMES) in the form of functional electrical stimulation (FES) applied to different lower limb muscles on reactive balance and gait performance in stroke participants. Methods: Twenty individuals with chronic stroke will be asked to perform an experimental protocol that includes a postural disturbance in the form of a slip- or trip-like perturbation and a standardized walking test in both laboratory and outdoor environments with and without FES applied to different lower limb muscles of the paretic leg. FES will be applied using an advanced software that is able to synchronize muscle activation with the time of perturbation onset and according to the phases of gait. This project design aims to examine whether a specific pattern of lower limb muscle stimulation could improve the kinematic and behavioral responses during reactive balance following slip- and trip-like perturbations. Additionally, the project aims to see if the kinematic and spatio-temporal gait parameters can be modified during a standardized walking test under different sensory and environmental conditions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment FES for improving balance and reducing fall risk in stroke patients?
Is electrical muscle stimulation safe for humans?
Research shows that neuromuscular electrical stimulation (NMES) is generally safe for humans, including those with implantable cardioverter defibrillators (ICDs), as long as individual risks are assessed beforehand. In a study with patients using ICDs, no adverse events were reported during long-term NMES treatment.678910
How does the treatment FES/NMES differ from other treatments for improving balance and reducing fall risk in stroke patients?
FES/NMES (Functional Electrical Stimulation/Neuromuscular Electrical Stimulation) is unique because it uses electrical impulses to stimulate muscles, helping to restore movement and improve balance in stroke patients. Unlike conventional therapy, FES can specifically target and activate paralyzed muscles, enhancing muscle function and balance more effectively.123411
Research Team
Tanvi Bhatt, PhD
Principal Investigator
University of Illinois at Chicago
Eligibility Criteria
This trial is for adults aged 18-90 who've had a stroke at least 6 months ago, can walk independently (with or without help) for at least 300 ft, and have no major health issues like heart disease or uncontrolled high blood pressure. They should be able to understand English and follow the study's instructions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Experimental Protocol
Participants undergo testing and training with NMES applied to lower limb muscles during slip- or trip-like perturbations and standardized walking tests.
Follow-up
Participants are monitored for safety and effectiveness after the experimental protocol
Treatment Details
Interventions
- FES
- NMES
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor